SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-003230
Filing Date
2023-02-17
Accepted
2023-02-17 16:46:37
Documents
13
Period of Report
2023-02-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20230214.htm   iXBRL 8-K 57647
2 EX-3.1 cytk-ex3_1.htm EX-3 224835
  Complete submission text file 0000950170-23-003230.txt   431564

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytk-20230214.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytk-20230214_pre.xml EX-101.PRE 10287
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytk-20230214_lab.xml EX-101.LAB 14019
7 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20230214_htm.xml XML 4934
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 23643438
SIC: 2834 Pharmaceutical Preparations